J. Pedro TeixeiraDivisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico
BouchardJ, AcharyaA, CerdaJ, MaccarielloER, MadarasuRC, TolwaniAJ, et al.: A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol10: 1324–1331, 201510.2215/CJN.04360514PubMed
BouchardJ, AcharyaA, CerdaJ, MaccarielloER, MadarasuRC, TolwaniAJ, : A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10: 1324–1331, 201510.2215/CJN.04360514PubMed)| false
GuptaS, CocaSG, ChanL, MelamedML, BrennerSK, HayekSS, the STOP-COVID Investigators, et al.: AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol32: 161–176, 202110.1681/ASN.2020060897PubMed
GuptaS, CocaSG, ChanL, MelamedML, BrennerSK, HayekSS, the STOP-COVID Investigators, : AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol 32: 161–176, 202110.1681/ASN.2020060897PubMed)| false
ZarbockA, KellumJA, SchmidtC, Van AkenH, WempeC, PavenstädtH, et al.: Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial. JAMA315: 2190–2199, 201610.1001/jama.2016.5828PubMed
ZarbockA, KellumJA, SchmidtC, Van AkenH, WempeC, PavenstädtH, : Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial. JAMA 315: 2190–2199, 201610.1001/jama.2016.5828PubMed)| false
GaudryS, HajageD, SchortgenF, Martin-LefevreL, PonsB, BouletE, AKIKI Study Group, et al.: Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med375: 122–133, 201610.1056/NEJMoa1603017PubMed
GaudryS, HajageD, SchortgenF, Martin-LefevreL, PonsB, BouletE, AKIKI Study Group, : Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375: 122–133, 201610.1056/NEJMoa1603017PubMed)| false
BarbarSD, Clere-JehlR, BourredjemA, HernuR, MontiniF, BruyèreR, et al.: Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med379: 1431–1442, 201810.1056/NEJMoa1803213PubMed
BarbarSD, Clere-JehlR, BourredjemA, HernuR, MontiniF, BruyèreR, : Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379: 1431–1442, 201810.1056/NEJMoa1803213PubMed)| false
BagshawSM, WaldR, AdhikariNKJ, BellomoR, da CostaBR, DreyfussD, Irish Critical Care Trials Group, et al.: Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med383: 240–251, 202010.1056/NEJMoa2000741PubMed
BagshawSM, WaldR, AdhikariNKJ, BellomoR, da CostaBR, DreyfussD, Irish Critical Care Trials Group, : Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383: 240–251, 202010.1056/NEJMoa2000741PubMed)| false
GaudryS, HajageD, Martin-LefevreL, LebbahS, LouisG, MoschiettoS, et al.: Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): A multicentre, open-label, randomised, controlled trial. Lancet397: 1293–1300, 202110.1016/S0140-6736(21)00350-0PubMed
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl2: 1–138, 2012
MeerschM, KüllmarM, SchmidtC, GerssJ, WeinhageT, MargrafA, et al.: Long-term clinical outcomes after early initiation of RRT in critically ill patients with AKI. J Am Soc Nephrol29: 1011–1019, 201810.1681/ASN.2017060694PubMed
MeerschM, KüllmarM, SchmidtC, GerssJ, WeinhageT, MargrafA, : Long-term clinical outcomes after early initiation of RRT in critically ill patients with AKI. J Am Soc Nephrol 29: 1011–1019, 201810.1681/ASN.2017060694PubMed)| false
ZampieriFG, da CostaBR, VaaraST, LamontagneF, RochwergB, NicholAD, STARRT-AKI Investigators, et al.: A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial. Crit Care26: 255, 202210.1186/s13054-022-04120-yPubMed
ZampieriFG, da CostaBR, VaaraST, LamontagneF, RochwergB, NicholAD, STARRT-AKI Investigators, : A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial. Crit Care 26: 255, 202210.1186/s13054-022-04120-yPubMed)| false
NaorungrojT, NetoAS, YanaseF, EastwoodG, WaldR, BagshawSM, et al.: Time to initiation of renal replacement therapy among critically ill patients with acute kidney injury: A current systematic review and meta-analysis. Crit Care Med49: e781–e792, 202110.1097/CCM.0000000000005018PubMed
NaorungrojT, NetoAS, YanaseF, EastwoodG, WaldR, BagshawSM, : Time to initiation of renal replacement therapy among critically ill patients with acute kidney injury: A current systematic review and meta-analysis. Crit Care Med 49: e781–e792, 202110.1097/CCM.0000000000005018PubMed)| false
CastroI, RelvasM, GameiroJ, LopesJA, Monteiro-SoaresM, CoentrãoL: The impact of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury on mortality and clinical outcomes: A meta-analysis. Clin Kidney J15: 1932–1945, 202210.1093/ckj/sfac139PubMed
CastroI, RelvasM, GameiroJ, LopesJA, Monteiro-SoaresM, CoentrãoL: The impact of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury on mortality and clinical outcomes: A meta-analysis. Clin Kidney J 15: 1932–1945, 202210.1093/ckj/sfac139PubMed)| false
ZampieriFG, Serpa-NetoA, WaldR, BellomoR, BagshawSM: Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials. J Crit Care82: 154767, 202410.1016/j.jcrc.2024.154767PubMed
ZampieriFG, Serpa-NetoA, WaldR, BellomoR, BagshawSM: Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials. J Crit Care 82: 154767, 202410.1016/j.jcrc.2024.154767PubMed)| false
OstermannM, BagshawSM, LumlertgulN, WaldR: Indications for and timing of initiation of KRT. Clin J Am Soc Nephrol18: 113–120, 202310.2215/CJN.05450522PubMed
OstermannM, BagshawSM, LumlertgulN, WaldR: Indications for and timing of initiation of KRT. Clin J Am Soc Nephrol 18: 113–120, 202310.2215/CJN.05450522PubMed)| false
LumlertgulN, PeerapornratanaS, TrakarnvanichT, PongsittisakW, SurasitK, ChuasuwanA, for the FST Study Group, et al.: Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care22: 101, 201810.1186/s13054-018-2021-1PubMed
LumlertgulN, PeerapornratanaS, TrakarnvanichT, PongsittisakW, SurasitK, ChuasuwanA, for the FST Study Group, : Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial). Crit Care 22: 101, 201810.1186/s13054-018-2021-1PubMed)| false
ChenY-T, PanH-C, HsuC-K, SunC-Y, ChenC-Y, ChenY-H, et al.: Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: A systematic review and meta-analysis. Crit Care27: 318, 202310.1186/s13054-023-04610-7PubMed
ChenY-T, PanH-C, HsuC-K, SunC-Y, ChenC-Y, ChenY-H, : Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: A systematic review and meta-analysis. Crit Care 27: 318, 202310.1186/s13054-023-04610-7PubMed)| false
KellyYP, MistryK, AhmedS, ShaykevichS, DesaiS, LipsitzSR, et al.: Controlled study of decision-making algorithms for kidney replacement therapy initiation in acute kidney injury. Clin J Am Soc Nephrol17: 194–204, 202210.2215/CJN.02060221PubMed
BlankestijnPJ, VernooijRWM, HockhamC, StrippoliGFM, CanaudB, HegbrantJ, CONVINCE Scientific Committee Investigators, et al.: Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med389: 700–709, 202310.1056/NEJMoa2304820PubMed
BlankestijnPJ, VernooijRWM, HockhamC, StrippoliGFM, CanaudB, HegbrantJ, CONVINCE Scientific Committee Investigators, : Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med 389: 700–709, 202310.1056/NEJMoa2304820PubMed)| false
CombesA, BréchotN, AmourJ, CozicN, LebretonG, GuidonC, et al.: Early high-volume hemofiltration versus standard care for post-cardiac surgery shock. The HEROICS study. Am J Respir Crit Care Med192: 1179–1190, 201510.1164/rccm.201503-0516OCPubMed
CombesA, BréchotN, AmourJ, CozicN, LebretonG, GuidonC, : Early high-volume hemofiltration versus standard care for post-cardiac surgery shock. The HEROICS study. Am J Respir Crit Care Med 192: 1179–1190, 201510.1164/rccm.201503-0516OCPubMed)| false
BrainM, WinsonE, RoodenburgO, McNeilJ: Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): A systematic review and meta-analysis. BMC Nephrol18: 69, 201710.1186/s12882-017-0445-5PubMed
BrainM, WinsonE, RoodenburgO, McNeilJ: Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): A systematic review and meta-analysis. BMC Nephrol 18: 69, 201710.1186/s12882-017-0445-5PubMed)| false
MannL, Ten EyckP, WuC, StoryM, JenigiriS, PatelJ, et al.: CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial. PLoS One18: e0278550, 202310.1371/journal.pone.0278550PubMed
MannL, Ten EyckP, WuC, StoryM, JenigiriS, PatelJ, : CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial. PLoS One 18: e0278550, 202310.1371/journal.pone.0278550PubMed)| false
VinsonneauC, CamusC, CombesA, Costa de BeauregardMA, KloucheK, BoulainT, Hemodiafe Study Group, et al.: Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet368: 379–385, 200610.1016/S0140-6736(06)69111-3PubMed
VinsonneauC, CamusC, CombesA, Costa de BeauregardMA, KloucheK, BoulainT, Hemodiafe Study Group, : Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 368: 379–385, 200610.1016/S0140-6736(06)69111-3PubMed)| false
LinsRL, ElseviersMM, Van der NiepenP, HosteE, MalbrainML, DamasP, SHARF investigators, et al.: Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: Results of a randomized clinical trial. Nephrol Dial Transplant24: 512–518, 200910.1093/ndt/gfn560PubMed
LinsRL, ElseviersMM, Van der NiepenP, HosteE, MalbrainML, DamasP, SHARF investigators, : Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: Results of a randomized clinical trial. Nephrol Dial Transplant 24: 512–518, 200910.1093/ndt/gfn560PubMed)| false
SchefoldJC, von HaehlingS, PschowskiR, BenderT, BerkmannC, BriegelS, et al.: The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial. Crit Care18: R11, 201410.1186/cc13188PubMed
SchefoldJC, von HaehlingS, PschowskiR, BenderT, BerkmannC, BriegelS, : The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial. Crit Care 18: R11, 201410.1186/cc13188PubMed)| false
SchneiderAG, BellomoR, BagshawSM, GlassfordNJ, LoS, JunM, et al.: Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: A systematic review and meta-analysis. Intensive Care Med39: 987–997, 201310.1007/s00134-013-2864-5PubMed
SchneiderAG, BellomoR, BagshawSM, GlassfordNJ, LoS, JunM, : Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: A systematic review and meta-analysis. Intensive Care Med 39: 987–997, 201310.1007/s00134-013-2864-5PubMed)| false
NaorungrojT, NetoAS, WangA, GallagherM, BellomoR: Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials. Crit Care26: 269, 202210.1186/s13054-022-04151-5PubMed
NaorungrojT, NetoAS, WangA, GallagherM, BellomoR: Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials. Crit Care 26: 269, 202210.1186/s13054-022-04151-5PubMed)| false
GaudryS, GrolleauF, BarbarS, Martin-LefevreL, PonsB, BouletÉ, et al.: Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: A secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care26: 93, 202210.1186/s13054-022-03955-9PubMed
GaudryS, GrolleauF, BarbarS, Martin-LefevreL, PonsB, BouletÉ, : Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: A secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care 26: 93, 202210.1186/s13054-022-03955-9PubMed)| false
WaldR, GaudryS, da CostaBR, AdhikariNKJ, BellomoR, DuB, STARRT-AKI Investigators, et al.: Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: A secondary analysis of STARRT-AKI trial. Intensive Care Med49: 1305–1316, 202310.1007/s00134-023-07211-8PubMed
WaldR, GaudryS, da CostaBR, AdhikariNKJ, BellomoR, DuB, STARRT-AKI Investigators, : Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: A secondary analysis of STARRT-AKI trial. Intensive Care Med 49: 1305–1316, 202310.1007/s00134-023-07211-8PubMed)| false
NashDM, PrzechS, WaldR, O’ReillyD: Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care41: 138–144, 201710.1016/j.jcrc.2017.05.002PubMed
NashDM, PrzechS, WaldR, O’ReillyD: Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care 41: 138–144, 201710.1016/j.jcrc.2017.05.002PubMed)| false
ZhaoY, ChenY: Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: A PRISMA-compliant systematic review and meta-analysis. Semin Dial33: 127–132, 202010.1111/sdi.12861PubMed
ZhaoY, ChenY: Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: A PRISMA-compliant systematic review and meta-analysis. Semin Dial 33: 127–132, 202010.1111/sdi.12861PubMed)| false
GhannoumM, RobertsDM, HoffmanRS, OuelletG, RoyL, DeckerBS, et al.: A stepwise approach for the management of poisoning with extracorporeal treatments. Semin Dial27: 362–370, 201410.1111/sdi.12228PubMed
GhannoumM, RobertsDM, HoffmanRS, OuelletG, RoyL, DeckerBS, : A stepwise approach for the management of poisoning with extracorporeal treatments. Semin Dial 27: 362–370, 201410.1111/sdi.12228PubMed)| false
AugustineJJ, SandyD, SeifertTH, PaganiniEP: A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis44: 1000–1007, 200410.1053/j.ajkd.2004.08.022PubMed
AugustineJJ, SandyD, SeifertTH, PaganiniEP: A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44: 1000–1007, 200410.1053/j.ajkd.2004.08.022PubMed)| false
BouchardJ, SorokoSB, ChertowGM, HimmelfarbJ, IkizlerTA, PaganiniEP, Program to Improve Care in Acute Renal Disease (PICARD) Study Group, et al.: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int76: 422–427, 200910.1038/ki.2009.159PubMed
BouchardJ, SorokoSB, ChertowGM, HimmelfarbJ, IkizlerTA, PaganiniEP, Program to Improve Care in Acute Renal Disease (PICARD) Study Group, : Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76: 422–427, 200910.1038/ki.2009.159PubMed)| false
DavenportA: Practical guidance for dialyzing a hemodialysis patient following acute brain injury. Hemodial Int 12: 307–312, 200810.1111/j.1542-4758.2008.00271.xPubMed)| false
BowesE, JoslinJ, Braide-AzikiweDCB, TulleyC, BramhamK, SahaS, et al.: Acute peritoneal dialysis with percutaneous catheter insertion for COVID-19-associated acute kidney injury in intensive care: Experience from a UK tertiary center. Kidney Int Rep6: 265–271, 202110.1016/j.ekir.2020.11.038PubMed
BowesE, JoslinJ, Braide-AzikiweDCB, TulleyC, BramhamK, SahaS, : Acute peritoneal dialysis with percutaneous catheter insertion for COVID-19-associated acute kidney injury in intensive care: Experience from a UK tertiary center. Kidney Int Rep 6: 265–271, 202110.1016/j.ekir.2020.11.038PubMed)| false
ChenW, CaplinN, El ShamyO, SharmaS, SourialMY, RossMJ, NYC-PD Consortium, et al.: Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: A multicenter observational study. Kidney Int100: 2–5, 202110.1016/j.kint.2021.04.017PubMed
ChenW, CaplinN, El ShamyO, SharmaS, SourialMY, RossMJ, NYC-PD Consortium, : Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: A multicenter observational study. Kidney Int 100: 2–5, 202110.1016/j.kint.2021.04.017PubMed)| false
GabrielDP, CaramoriJT, MartimLC, BarrettiP, BalbiAL: High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl : S87–S93, 200810.1038/sj.ki.5002608PubMed
GabrielDP, CaramoriJT, MartimLC, BarrettiP, BalbiAL: High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl : S87–S93, 200810.1038/sj.ki.5002608PubMed)| false
PonceD, BerbelMN, AbraoJM, GoesCR, BalbiAL: A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol45: 869–878, 201310.1007/s11255-012-0301-2PubMed
PonceD, BerbelMN, AbraoJM, GoesCR, BalbiAL: A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol 45: 869–878, 201310.1007/s11255-012-0301-2PubMed)| false
ChionhCY, SoniSS, FinkelsteinFO, RoncoC, CruzDN: Use of peritoneal dialysis in AKI: A systematic review. Clin J Am Soc Nephrol8: 1649–1660, 201310.2215/CJN.01540213PubMed
ChionhCY, SoniSS, FinkelsteinFO, RoncoC, CruzDN: Use of peritoneal dialysis in AKI: A systematic review. Clin J Am Soc Nephrol 8: 1649–1660, 201310.2215/CJN.01540213PubMed)| false
ParientiJ-J, ThirionM, MégarbaneB, SouweineB, OuchikheA, PolitoA, Members of the Cathedia Study Group, et al.: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA299: 2413–2422, 200810.1001/jama.299.20.2413PubMed
ParientiJ-J, ThirionM, MégarbaneB, SouweineB, OuchikheA, PolitoA, Members of the Cathedia Study Group, : Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA 299: 2413–2422, 200810.1001/jama.299.20.2413PubMed)| false
MorganD, HoK, MurrayC, DaviesH, LouwJ: A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy. Am J Kidney Dis60: 272–279, 201210.1053/j.ajkd.2012.01.021PubMed
MorganD, HoK, MurrayC, DaviesH, LouwJ: A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy. Am J Kidney Dis 60: 272–279, 201210.1053/j.ajkd.2012.01.021PubMed)| false
ParientiJ-J, MégarbaneB, FischerM-O, LautretteA, GazuiN, MarinN, Cathedia Study Group, et al.: Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Crit Care Med38: 1118–1125, 201010.1097/CCM.0b013e3181d454b3PubMed
ParientiJ-J, MégarbaneB, FischerM-O, LautretteA, GazuiN, MarinN, Cathedia Study Group, : Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Crit Care Med 38: 1118–1125, 201010.1097/CCM.0b013e3181d454b3PubMed)| false
WeijmerMC, VervloetMG, ter WeePM: Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant19: 670–677, 200410.1093/ndt/gfg581PubMed
WeijmerMC, VervloetMG, ter WeePM: Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19: 670–677, 200410.1093/ndt/gfg581PubMed)| false
KimDH, YounS, BanTH, ChoiBS, KimBS, ParkCW, et al.: Safety and durable patency of tunneled hemodialysis catheter inserted without fluoroscopy. Kidney Res Clin Pract42: 723–730, 202310.23876/j.krcp.22.282PubMed
PrasadP, VachharajaniTJ: Non-fluoroscopic techniques to insert a tunneled hemodialysis catheter. Kidney Int Rep8: 2191–2193, 202310.1016/j.ekir.2023.09.023PubMed
Al RifaiA, SukulN, WonnacottR, HeungM: Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience. Hemodial Int22: 50–55, 201810.1111/hdi.12550PubMed
Al RifaiA, SukulN, WonnacottR, HeungM: Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience. Hemodial Int 22: 50–55, 201810.1111/hdi.12550PubMed)| false
SantiagoMJ, SánchezA, López-HerceJ, PérezR, del CastilloJ, UrbanoJ, et al.: The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int76: 1289–1292, 200910.1038/ki.2009.383PubMed
SantiagoMJ, SánchezA, López-HerceJ, PérezR, del CastilloJ, UrbanoJ, : The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int 76: 1289–1292, 200910.1038/ki.2009.383PubMed)| false
de TymowskiC, DesmardM, Lortat-JacobB, PellencQ, AlkhoderS, AlouacheA, et al.: Impact of connecting continuous renal replacement therapy to the extracorporeal membrane oxygenation circuit. Anaesth Crit Care Pain Med37: 557–564, 201810.1016/j.accpm.2018.02.024PubMed
de TymowskiC, DesmardM, Lortat-JacobB, PellencQ, AlkhoderS, AlouacheA, : Impact of connecting continuous renal replacement therapy to the extracorporeal membrane oxygenation circuit. Anaesth Crit Care Pain Med 37: 557–564, 201810.1016/j.accpm.2018.02.024PubMed)| false
RuizEF, Ortiz-SorianoVM, TalbottM, KleinBA, Thompson BastinML, MayerKP, University of Kentucky CRRT Quality Assurance Group, et al.: Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit. Sci Rep10: 20616, 202010.1038/s41598-020-76785-wPubMed
RuizEF, Ortiz-SorianoVM, TalbottM, KleinBA, Thompson BastinML, MayerKP, University of Kentucky CRRT Quality Assurance Group, : Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit. Sci Rep 10: 20616, 202010.1038/s41598-020-76785-wPubMed)| false
UchinoS, TokiN, TakedaK, OhnumaT, NambaY, KatayamaS, Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group, et al.: Validity of low-intensity continuous renal replacement therapy. Crit Care Med41: 2584–2591, 201310.1097/CCM.0b013e318298622ePubMed
UchinoS, TokiN, TakedaK, OhnumaT, NambaY, KatayamaS, Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group, : Validity of low-intensity continuous renal replacement therapy. Crit Care Med 41: 2584–2591, 201310.1097/CCM.0b013e318298622ePubMed)| false
Division of Nephrology CUVCoP: Disaster response to the COVID-19 pandemic for patients with kidney disease in New York City. J Am Soc Nephrol31: 1371–1379, 202010.1681/ASN.2020040520PubMed
Division of Nephrology CUVCoP: Disaster response to the COVID-19 pandemic for patients with kidney disease in New York City. J Am Soc Nephrol 31: 1371–1379, 202010.1681/ASN.2020040520PubMed)| false
TeixeiraJP, SaaL, KaucherKA, VillanuevaRD, ShiehM, BacaCR, et al.: Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic. BMC Nephrol24: 245, 202310.1186/s12882-023-03260-9PubMed
TeixeiraJP, SaaL, KaucherKA, VillanuevaRD, ShiehM, BacaCR, : Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic. BMC Nephrol 24: 245, 202310.1186/s12882-023-03260-9PubMed)| false
SchifflH, LangSM, FischerR: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–310, 200210.1056/NEJMoa010877PubMed)| false
Faulhaber-WalterR, HaferC, JahrN, VahlbruchJ, HoyL, HallerH, et al.: The Hannover Dialysis Outcome study: Comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant24: 2179–2186, 200910.1093/ndt/gfp035PubMed
Faulhaber-WalterR, HaferC, JahrN, VahlbruchJ, HoyL, HallerH, : The Hannover Dialysis Outcome study: Comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24: 2179–2186, 200910.1093/ndt/gfp035PubMed)| false
LiangKV, ZhangJH, PalevskyPM: Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury. BMC Nephrol20: 82, 201910.1186/s12882-019-1272-7PubMed
LiangKV, ZhangJH, PalevskyPM: Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury. BMC Nephrol 20: 82, 201910.1186/s12882-019-1272-7PubMed)| false
PonceD, BritoGA, AbraoJG, BalbAL: Different prescribed doses of high-volume peritoneal dialysis and outcome of patients with acute kidney injury. Adv Perit Dial27: 118–124, 2011PubMed
ParapiboonW, JamratpanT: Intensive versus minimal standard dosage for peritoneal dialysis in acute kidney injury: A randomized pilot study. Perit Dial Int37: 523–528, 201710.3747/pdi.2016.00260PubMed
ParapiboonW, JamratpanT: Intensive versus minimal standard dosage for peritoneal dialysis in acute kidney injury: A randomized pilot study. Perit Dial Int 37: 523–528, 201710.3747/pdi.2016.00260PubMed)| false
LiuC, MaoZ, KangH, HuJ, ZhouF: Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care 20: 144, 201610.1186/s13054-016-1299-0PubMed)| false
ZhengY, ZhuangF, ZhuQ, MaS, XuY, LuJ, et al.: Albumin-corrected total/ionized calcium ratio is not superior to total/ionized calcium ratio as an indicator of citrate accumulation. Int J Artif Organs40: 602–606, 201710.5301/ijao.5000621PubMed
ZhengY, ZhuangF, ZhuQ, MaS, XuY, LuJ, : Albumin-corrected total/ionized calcium ratio is not superior to total/ionized calcium ratio as an indicator of citrate accumulation. Int J Artif Organs 40: 602–606, 201710.5301/ijao.5000621PubMed)| false
DavenportA, TolwaniA: Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus2: 439–447, 200910.1093/ndtplus/sfp136PubMed
DavenportA, TolwaniA: Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus 2: 439–447, 200910.1093/ndtplus/sfp136PubMed)| false
Meier-KriescheHU, GitomerJ, FinkelK, DuBoseT: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med29: 748–752, 200110.1097/00003246-200104000-00010PubMed
Meier-KriescheHU, GitomerJ, FinkelK, DuBoseT: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29: 748–752, 200110.1097/00003246-200104000-00010PubMed)| false
ZarbockA, KüllmarM, Kindgen-MillesD, WempeC, GerssJ, BrandenburgerT, RICH Investigators and the Sepnet Trial Group, et al.: Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: A randomized clinical trial. JAMA324: 1629–1639, 202010.1001/jama.2020.18618PubMed
ZarbockA, KüllmarM, Kindgen-MillesD, WempeC, GerssJ, BrandenburgerT, RICH Investigators and the Sepnet Trial Group, : Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: A randomized clinical trial. JAMA 324: 1629–1639, 202010.1001/jama.2020.18618PubMed)| false
GerssJ, MeerschM, Kindgen-MillesD, BrandenburgerT, WillamC, KellumJA, et al.: The effect of filter lifespan during continuous renal replacement therapy in critically ill patients with AKI on the rate of new onset infection: Analysis from the RICH randomized controlled trial. Am J Respir Crit Care Med206: 511–514, 202210.1164/rccm.202201-0063LEPubMed
GerssJ, MeerschM, Kindgen-MillesD, BrandenburgerT, WillamC, KellumJA, : The effect of filter lifespan during continuous renal replacement therapy in critically ill patients with AKI on the rate of new onset infection: Analysis from the RICH randomized controlled trial. Am J Respir Crit Care Med 206: 511–514, 202210.1164/rccm.202201-0063LEPubMed)| false
Di MarcoGS, ChasanAI, BoeckelGR, BeulK, PavenstädtH, RothJ, et al.: Monocytes as targets for immunomodulation by regional citrate anticoagulation. Int J Mol Sci25: 2900, 202410.3390/ijms25052900PubMed
Di MarcoGS, ChasanAI, BoeckelGR, BeulK, PavenstädtH, RothJ, : Monocytes as targets for immunomodulation by regional citrate anticoagulation. Int J Mol Sci 25: 2900, 202410.3390/ijms25052900PubMed)| false
ZhangW, BaiM, YuY, LiL, ZhaoL, SunS, et al.: Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: A systematic review and meta-analysis. Crit Care23: 22, 201910.1186/s13054-019-2317-9PubMed
ZhangW, BaiM, YuY, LiL, ZhaoL, SunS, : Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: A systematic review and meta-analysis. Crit Care 23: 22, 201910.1186/s13054-019-2317-9PubMed)| false
BaiM, YuY, ZhaoL, TianX, ZhouM, JiaoJ, et al.: Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk. Clin J Am Soc Nephrol19: 151–160, 202310.2215/CJN.0000000000000351PubMed
BaiM, YuY, ZhaoL, TianX, ZhouM, JiaoJ, : Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk. Clin J Am Soc Nephrol 19: 151–160, 202310.2215/CJN.0000000000000351PubMed)| false
LinY, ShaoY, LiuY, YangR, LiaoS, YangS, et al.: Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: A systematic review and meta-analysis. Ren Fail44: 1263–1279, 202210.1080/0886022X.2022.2105233PubMed
LiuD, ZhaoJ, XiaH, DongS, YanS, ZhuangY, et al.: Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: A retrospective single-center study. Eur J Med Res29: 72, 202410.1186/s40001-024-01660-7PubMed
LiuD, ZhaoJ, XiaH, DongS, YanS, ZhuangY, : Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: A retrospective single-center study. Eur J Med Res 29: 72, 202410.1186/s40001-024-01660-7PubMed)| false
FealyN, AitkenL, Du ToitE, LoS, BaldwinI: Faster blood flow rate does not improve circuit life in continuous renal replacement therapy: A randomized controlled trial. Crit Care Med45: e1018–e1025, 201710.1097/CCM.0000000000002568PubMed
FealyN, AitkenL, Du ToitE, LoS, BaldwinI: Faster blood flow rate does not improve circuit life in continuous renal replacement therapy: A randomized controlled trial. Crit Care Med 45: e1018–e1025, 201710.1097/CCM.0000000000002568PubMed)| false
HatamizadehP, TolwaniA, PalevskyP: Revisiting filtration fraction as an index of the risk of hemofilter clotting in continuous venovenous hemofiltration. Clin J Am Soc Nephrol15: 1660–1662, 202010.2215/CJN.02410220PubMed
HatamizadehP, TolwaniA, PalevskyP: Revisiting filtration fraction as an index of the risk of hemofilter clotting in continuous venovenous hemofiltration. Clin J Am Soc Nephrol 15: 1660–1662, 202010.2215/CJN.02410220PubMed)| false
BitkerL, BayleF, YonisH, GobertF, LerayV, TaponnierR, et al.: Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care20: 44, 201610.1186/s13054-016-1227-3PubMed
BitkerL, BayleF, YonisH, GobertF, LerayV, TaponnierR, : Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care 20: 44, 201610.1186/s13054-016-1227-3PubMed)| false
DouvrisA, ZeidK, HiremathS, BagshawSM, WaldR, Beaubien-SoulignyW, et al.: Mechanisms for hemodynamic instability related to renal replacement therapy: A narrative review. Intensive Care Med45: 1333–1346, 201910.1007/s00134-019-05707-wPubMed
DouvrisA, ZeidK, HiremathS, BagshawSM, WaldR, Beaubien-SoulignyW, : Mechanisms for hemodynamic instability related to renal replacement therapy: A narrative review. Intensive Care Med 45: 1333–1346, 201910.1007/s00134-019-05707-wPubMed)| false
MuruganR, KertiSJ, ChangC-CH, GallagherM, ClermontG, PalevskyPM, et al.: Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial. JAMA Netw Open2: e195418, 201910.1001/jamanetworkopen.2019.5418PubMed
MuruganR, KertiSJ, ChangC-CH, GallagherM, ClermontG, PalevskyPM, : Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial. JAMA Netw Open 2: e195418, 201910.1001/jamanetworkopen.2019.5418PubMed)| false
Beaubien-SoulignyW, TrottT, NeyraJA: How to determine fluid management goals during continuous kidney replacement therapy in patients with AKI: Focus on POCUS. Kidney3603: 1795–1806, 202210.34067/KID.0002822022PubMed
Beaubien-SoulignyW, TrottT, NeyraJA: How to determine fluid management goals during continuous kidney replacement therapy in patients with AKI: Focus on POCUS. Kidney360 3: 1795–1806, 202210.34067/KID.0002822022PubMed)| false
TeixeiraJP, ZeidmanA, Beaubien-SoulignyW, CerdáJ, ConnorMJ, EgglestonK, et al.: Proceedings of the 2022 UAB CRRT Academy: Non-invasive hemodynamic monitoring to guide fluid removal with CRRT and proliferation of extracorporeal blood purification devices. Blood Purif52: 857–879, 202310.1159/000533573PubMed
WuV-C, KoW-J, ChangH-W, ChenY-W, LinY-F, ShiaoC-C, National Taiwan University Surgical ICU Acute Renal Failure Study Group (NSARF), et al.: Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med34: 101–108, 200810.1007/s00134-007-0813-xPubMed
WuV-C, KoW-J, ChangH-W, ChenY-W, LinY-F, ShiaoC-C, National Taiwan University Surgical ICU Acute Renal Failure Study Group (NSARF), : Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 34: 101–108, 200810.1007/s00134-007-0813-xPubMed)| false
UchinoS, BellomoR, MorimatsuH, MorgeraS, SchetzM, TanI, et al.: Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study. Crit Care Med37: 2576–2582, 200910.1097/CCM.0b013e3181a38241PubMed
UchinoS, BellomoR, MorimatsuH, MorgeraS, SchetzM, TanI, : Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study. Crit Care Med 37: 2576–2582, 200910.1097/CCM.0b013e3181a38241PubMed)| false
JeonJ, KimDH, BaegSI, LeeEJ, ChungCR, JeonK, et al.: Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Crit Care22: 255, 201810.1186/s13054-018-2192-9PubMed
JeonJ, KimDH, BaegSI, LeeEJ, ChungCR, JeonK, : Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Crit Care 22: 255, 201810.1186/s13054-018-2192-9PubMed)| false
Beaubien-SoulignyW, YangY, BurnsKEA, FriedrichJO, Meraz-MuñozA, ClarkEG, et al.: Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy. Ann Intensive Care11: 96, 202110.1186/s13613-021-00885-7PubMed
Beaubien-SoulignyW, YangY, BurnsKEA, FriedrichJO, Meraz-MuñozA, ClarkEG, : Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy. Ann Intensive Care 11: 96, 202110.1186/s13613-021-00885-7PubMed)| false
KatulkaRJ, Al SaadonA, SebastianskiM, FeatherstoneR, VandermeerB, SilverSA, et al.: Determining the optimal time for liberation from renal replacement therapy in critically ill patients: A systematic review and meta-analysis (DOnE RRT). Crit Care24: 50, 202010.1186/s13054-020-2751-8PubMed
KatulkaRJ, Al SaadonA, SebastianskiM, FeatherstoneR, VandermeerB, SilverSA, : Determining the optimal time for liberation from renal replacement therapy in critically ill patients: A systematic review and meta-analysis (DOnE RRT). Crit Care 24: 50, 202010.1186/s13054-020-2751-8PubMed)| false
von GrooteT, AlbertF, MeerschM, KochR, PorschenC, HartmannO, et al.: Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: A post hoc analysis of the ELAIN trial. Crit Care26: 333, 202210.1186/s13054-022-04217-4PubMed
von GrooteT, AlbertF, MeerschM, KochR, PorschenC, HartmannO, : Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: A post hoc analysis of the ELAIN trial. Crit Care 26: 333, 202210.1186/s13054-022-04217-4PubMed)| false
von GrooteT, AlbertF, MeerschM, KochR, GerssJ, ArltB, RICH investigators, et al.: Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: An external, multicenter pilot study in critically ill patients with acute kidney injury. Crit Care27: 276, 202310.1186/s13054-023-04556-wPubMed
von GrooteT, AlbertF, MeerschM, KochR, GerssJ, ArltB, RICH investigators, : Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: An external, multicenter pilot study in critically ill patients with acute kidney injury. Crit Care 27: 276, 202310.1186/s13054-023-04556-wPubMed)| false
AllegrettiAS, EndresP, ParrisT, ZhaoS, MayM, Sylvia-ReardonM, et al.: Accelerated venovenous hemofiltration as a transitional renal replacement therapy in the intensive care unit. Am J Nephrol51: 318–326, 202010.1159/000506412PubMed
AllegrettiAS, EndresP, ParrisT, ZhaoS, MayM, Sylvia-ReardonM, : Accelerated venovenous hemofiltration as a transitional renal replacement therapy in the intensive care unit. Am J Nephrol 51: 318–326, 202010.1159/000506412PubMed)| false
GriffinBR, JovanovichA, YouZ, PalevskyP, FaubelS, JalalD: Effects of baseline thrombocytopenia and platelet decrease following renal replacement therapy initiation in patients with severe acute kidney injury. Crit Care Med47: e325–e331, 201910.1097/CCM.0000000000003598PubMed
GriffinBR, JovanovichA, YouZ, PalevskyP, FaubelS, JalalD: Effects of baseline thrombocytopenia and platelet decrease following renal replacement therapy initiation in patients with severe acute kidney injury. Crit Care Med 47: e325–e331, 201910.1097/CCM.0000000000003598PubMed)| false
GriffinBR, WuC, O’HoroJC, FaubelS, JalalD, KashaniK: The association of platelet decrease following continuous renal replacement therapy initiation and increased rates of secondary infections. Crit Care Med49: e130–e139, 202110.1097/CCM.0000000000004763PubMed
GriffinBR, WuC, O’HoroJC, FaubelS, JalalD, KashaniK: The association of platelet decrease following continuous renal replacement therapy initiation and increased rates of secondary infections. Crit Care Med 49: e130–e139, 202110.1097/CCM.0000000000004763PubMed)| false
Thompson BastinML, StrombergAJ, NerusuSN, LiuLJ, MayerKP, LiuKD, et al.: Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol17: 634–642, 202210.2215/CJN.12410921PubMed
Thompson BastinML, StrombergAJ, NerusuSN, LiuLJ, MayerKP, LiuKD, : Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol 17: 634–642, 202210.2215/CJN.12410921PubMed)| false
CrowleyKE, DeGradoJR, CharytanDM: Serum glucose and phosphorus concentrations during continuous renal replacement therapy using commercial replacement solutions with or without phosphorus. Hemodial Int24: 330–334, 202010.1111/hdi.12834PubMed
CrowleyKE, DeGradoJR, CharytanDM: Serum glucose and phosphorus concentrations during continuous renal replacement therapy using commercial replacement solutions with or without phosphorus. Hemodial Int 24: 330–334, 202010.1111/hdi.12834PubMed)| false
CoutrotM, HékimianG, MoulinT, BréchotN, SchmidtM, BessetS, et al.: Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions. Intensive Care Med44: 1185–1186, 201810.1007/s00134-018-5118-8PubMed
CoutrotM, HékimianG, MoulinT, BréchotN, SchmidtM, BessetS, : Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions. Intensive Care Med 44: 1185–1186, 201810.1007/s00134-018-5118-8PubMed)| false
RewaOG, TolwaniA, MottesT, JuncosLA, RoncoC, KashaniK, ADQI Consensus Meeting Members on behalf of ADQI XXII, et al.: Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference. J Crit Care54: 52–57, 201910.1016/j.jcrc.2019.07.003PubMed
RewaOG, TolwaniA, MottesT, JuncosLA, RoncoC, KashaniK, ADQI Consensus Meeting Members on behalf of ADQI XXII, : Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference. J Crit Care 54: 52–57, 201910.1016/j.jcrc.2019.07.003PubMed)| false
RewaOG, VilleneuveP-M, LachanceP, EurichDT, StelfoxHT, GibneyRTN, et al.: Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review. Intensive Care Med43: 750–763, 201710.1007/s00134-016-4579-xPubMed
RewaOG, VilleneuveP-M, LachanceP, EurichDT, StelfoxHT, GibneyRTN, : Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review. Intensive Care Med 43: 750–763, 201710.1007/s00134-016-4579-xPubMed)| false
NeyraJA, NadkarniGN: Continuous kidney replacement therapy of the future: Innovations in information technology, data analytics, and quality assurance systems. Adv Chronic Kidney Dis28: 13–19, 202110.1053/j.ackd.2021.03.020PubMed
NeyraJA, NadkarniGN: Continuous kidney replacement therapy of the future: Innovations in information technology, data analytics, and quality assurance systems. Adv Chronic Kidney Dis 28: 13–19, 202110.1053/j.ackd.2021.03.020PubMed)| false
NeyraJA, KashaniK: Improving the quality of care for patients requiring continuous renal replacement therapy. Semin Dial34: 501–509, 202110.1111/sdi.12968PubMed
NeyraJA, KashaniK: Improving the quality of care for patients requiring continuous renal replacement therapy. Semin Dial 34: 501–509, 202110.1111/sdi.12968PubMed)| false
NeyraJA, GoldsteinSL: Optimizing renal replacement therapy deliverables through multidisciplinary work in the intensive care unit. Clin Nephrol90: 1–5, 201810.5414/CN109447PubMed
NeyraJA, GoldsteinSL: Optimizing renal replacement therapy deliverables through multidisciplinary work in the intensive care unit. Clin Nephrol 90: 1–5, 201810.5414/CN109447PubMed)| false
OnichimowskiD, ZiółkowskiH, NosekK, JaroszewskiJ, RypulakE, CzuczwarM: Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: In vitro studies. J Artif Organs23: 163–170, 202010.1007/s10047-019-01139-xPubMed
LewisSJ, MuellerBA: Antibiotic dosing in patients with acute kidney injury: “Enough but not too much.”J Intensive Care Med31: 164–176, 201610.1177/0885066614555490PubMed
LewisSJ, MuellerBA: Antibiotic dosing in patients with acute kidney injury: “Enough but not too much.”J Intensive Care Med 31: 164–176, 201610.1177/0885066614555490PubMed)| false
TeixeiraJP, MayerKP, GriffinBR, GeorgeN, JenkinsN, PalCA, et al.: Intensive care unit-acquired weakness in patients with acute kidney injury: A contemporary review. Am J Kidney Dis81: 336–351, 202310.1053/j.ajkd.2022.08.028PubMed
McClaveSA, TaylorBE, MartindaleRG, WarrenMM, JohnsonDR, BraunschweigC, American Society for Parenteral and Enteral Nutrition, et al.: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr40: 159–211, 201610.1177/0148607115621863PubMed
McClaveSA, TaylorBE, MartindaleRG, WarrenMM, JohnsonDR, BraunschweigC, American Society for Parenteral and Enteral Nutrition, : Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 40: 159–211, 201610.1177/0148607115621863PubMed)| false
Raurell-TorredàM, Arias-RiveraS, MartíJD, Frade-MeraMJ, Zaragoza-GarcíaI, GallartE, MOviPre group, et al.: Care and treatments related to intensive care unit-acquired muscle weakness: A cohort study. Aust Crit Care34: 435–445, 202110.1016/j.aucc.2020.12.005PubMed
Raurell-TorredàM, Arias-RiveraS, MartíJD, Frade-MeraMJ, Zaragoza-GarcíaI, GallartE, MOviPre group, : Care and treatments related to intensive care unit-acquired muscle weakness: A cohort study. Aust Crit Care 34: 435–445, 202110.1016/j.aucc.2020.12.005PubMed)| false
MayerKP, Ortiz-SorianoVM, KalantarA, LambertJ, MorrisPE, NeyraJA: Acute kidney injury contributes to worse physical and quality of life outcomes in survivors of critical illness. BMC Nephrol23: 137, 202210.1186/s12882-022-02749-zPubMed
MayerKP, Ortiz-SorianoVM, KalantarA, LambertJ, MorrisPE, NeyraJA: Acute kidney injury contributes to worse physical and quality of life outcomes in survivors of critical illness. BMC Nephrol 23: 137, 202210.1186/s12882-022-02749-zPubMed)| false
MayerKP, Joseph-IsangE, RobinsonLE, ParrySM, MorrisPE, NeyraJA: Safety and feasibility of physical rehabilitation and active mobilization in patients requiring continuous renal replacement therapy: A systematic review. Crit Care Med48: e1112–e1120, 202010.1097/CCM.0000000000004526PubMed
MayerKP, Joseph-IsangE, RobinsonLE, ParrySM, MorrisPE, NeyraJA: Safety and feasibility of physical rehabilitation and active mobilization in patients requiring continuous renal replacement therapy: A systematic review. Crit Care Med 48: e1112–e1120, 202010.1097/CCM.0000000000004526PubMed)| false
MayerKP, HornsbyAR, SorianoVO, LinTC, CunninghamJT, YuanH, et al.: Safety, feasibility, and efficacy of early rehabilitation in patients requiring continuous renal replacement: A quality improvement study. Kidney Int Rep5: 39–47, 202010.1016/j.ekir.2019.10.003PubMed